MedTrace Logo

fMRI Accelerated TMS Depression

NCT06562153 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-10-16

No results posted yet for this study

Summary

This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerated antidepressant transcranial magnetic stimulation (TMS) treatment.

Conditions

Interventions

OTHER

Neuroimaging with Magnetic Resonance Imaging (MRI)

MRI will be used to observe brain states over time.

Sponsors & Collaborators

  • Foundation for the Advancement of Clinical TMS

    collaborator UNKNOWN

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Xiaolong Peng · Medical University of South Carolina

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-23
Primary Completion
2026-08-05
Completion
2026-08-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06562153 on ClinicalTrials.gov